The U.S. Food and Drug Administration (FDA) has approved a new oral solution formulation of Evoxac (cevimeline hydrochloride), a long-used treatment for dry mouth in adults with Sjögren’s disease, offering an alternative for patients who have difficulty swallowing capsules. Developed by Cosette Pharmaceuticals, the new formulation contains…
Discussion
A panel of four blood markers may help identify people with Sjögren’s disease, even those who lack common disease-associated antibodies, a new study finds. Researchers also identified blood marker panels linked to overall disease activity and involvement of specific organs. Although more studies are needed to confirm the results,…
Discussion
A Florida man is preparing to pilot a stand-up paddleboard 540 miles along the state’s Intracoastal Waterway to raise awareness and research funds for Sjögren’s disease, a chronic autoimmune condition his daughter was diagnosed with at age 11 after two years of painful symptoms and unanswered questions. Jason Parker,…
Discussion
Argenx is stopping a global clinical trial testing its drug efgartigimod against a placebo in adults with moderate to severe Sjögren’s disease after an independent analysis deemed the study unlikely to meet its main goal. Based on a predefined interim analysis of the trial’s data, an independent data…
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Get regular updates to your inbox.
